Product name: BAM‑15 — Paragon Pharmatech 20 mg Capsules
Strength per capsule: 20 mg BAM‑15
Capsules per bottle: 60 vegetarian capsules
Other names: BAM15; mitochondrial uncoupler BAM‑15; N5,N6‑bis(2‑fluorophenyl)[2,1,3]oxadiazolo[4,5‑b]pyrazine‑5,6‑diamine
CAS number: 210302‑17‑3
Molecular formula / weight: C16H10F2N6O, ~340.29 g·mol⁻¹
Chemical class / structure: Synthetic small‑molecule mitochondrial protonophore belonging to the oxadiazolo‑pyrazine family; lipophilic heterocyclic aromatic structure with fluorophenyl substituents enabling membrane permeability and proton shuttling.
PubChem CID: 565708

10 Strong Points & Benefits 

1. Selective mitochondrial uncoupling: BAM‑15 dissipates the mitochondrial proton gradient without depolarizing the plasma membrane, distinguishing it from earlier uncouplers such as FCCP. (axonmedchem.com)

2. Increased energy expenditure: Animal studies demonstrate increased nutrient oxidation and metabolic rate following administration. (pmc.ncbi.nlm.nih.gov)

3. Reduction of body fat in preclinical models: Multiple mouse studies show decreased adiposity and resistance to diet‑induced obesity. (embopress.org)

4. Improved insulin sensitivity and glucose metabolism: Hyperinsulinemic clamp studies show improved insulin action in muscle and liver tissue. (pmc.ncbi.nlm.nih.gov)

5. Reduced hepatic fat and inflammatory lipids: BAM‑15 improves markers of fatty liver and systemic inflammation in experimental models. (pmc.ncbi.nlm.nih.gov)

6. Protection against oxidative stress and mitochondrial dysfunction: Studies demonstrate decreased mitochondrial ROS and improved respiratory efficiency. (jci.org)

7. Potential cardiometabolic and vascular benefits: Research suggests improved fatty‑acid oxidation and endothelial protection in metabolic disease models. (mdpi.com)

8. Neuroprotective and anti‑aging signals in model organisms: Experimental work shows improved neuronal integrity and lifespan markers in laboratory models. (mdpi.com)

9. Anti‑tumor and immunomodulatory research applications: BAM‑15 has been shown to inhibit proliferation in some cancer models and modulate immune responses. (papers.ssrn.com)

10. Favorable tolerability in preclinical research: Reviews indicate encouraging safety signals in animal studies compared with older uncouplers. (pubmed.ncbi.nlm.nih.gov)

Overview

BAM‑15 is a synthetic small‑molecule mitochondrial uncoupler developed to investigate the role of mitochondrial efficiency and bioenergetics in metabolic disease, aging, and inflammatory disorders. Mitochondrial uncoupling refers to the dissipation of the proton gradient across the inner mitochondrial membrane, allowing electron transport to continue while reducing ATP synthesis efficiency and increasing heat and substrate oxidation.

Interest in mitochondrial uncouplers dates back to early twentieth‑century compounds such as dinitrophenol (DNP), which demonstrated potent metabolic effects but unacceptable toxicity. BAM‑15 was developed to retain the beneficial metabolic actions of uncoupling while minimizing systemic toxicity and avoiding plasma‑membrane depolarization.

Preclinical research shows that BAM‑15 increases mitochondrial respiration, enhances fatty‑acid oxidation, reduces adiposity, improves insulin sensitivity, and protects tissues from oxidative damage. Animal studies also demonstrate beneficial effects in models of obesity, diabetes, ischemia‑reperfusion injury, and sepsis.

The compound’s favorable preclinical safety profile and oral bioavailability have generated significant interest in mitochondrial medicine and metabolic research, although human clinical trials remain limited and the compound remains investigational.

Paragon Pharmatech manufactures BAM‑15 capsules containing 20 mg per capsule under GMP‑aligned quality standards, providing a consistent formulation suitable for scientific and laboratory research applications.

How It Works (Mechanisms & Pharmacology)

1. Mitochondrial Protonophore Activity

BAM‑15 functions as a protonophore that transports protons across the inner mitochondrial membrane independent of ATP synthase. This process reduces the electrochemical gradient and stimulates increased electron transport and oxygen consumption. (medkoo.com)

2. Increased Energy Expenditure and Fatty‑Acid Oxidation

By uncoupling oxidative phosphorylation, cells increase substrate oxidation to maintain ATP levels. This increased metabolic flux leads to higher energy expenditure and enhanced fatty‑acid utilization. (pubmed.ncbi.nlm.nih.gov)

3. Reduction of Reactive Oxygen Species

Moderate uncoupling decreases mitochondrial membrane potential, which reduces electron leakage and ROS generation, protecting cellular structures from oxidative damage. (jci.org)

4. AMPK Activation and Metabolic Signaling

Increased energy demand activates AMP‑activated protein kinase (AMPK), promoting glucose uptake, fatty‑acid oxidation, and improved insulin signaling. (link.springer.com)

5. Pharmacokinetics and Bioavailability

Studies in rodents demonstrate oral bioavailability of BAM‑15 and systemic metabolic effects following oral dosing, supporting its suitability as a research tool. (nature.com)

What Studies Have Shown 

Obesity and Metabolic Disease

Several landmark studies demonstrated that BAM‑15 reverses diet‑induced obesity in mice by increasing energy expenditure without reducing food intake or lean body mass. (nature.com)
These studies also showed reductions in hepatic steatosis, inflammatory markers, and improvements in insulin sensitivity.

Insulin Resistance and Glucose Homeostasis

Hyperinsulinemic clamp studies and metabolic phenotyping demonstrate improved insulin action in skeletal muscle, liver, and adipose tissue following BAM‑15 treatment. (pmc.ncbi.nlm.nih.gov)

Sepsis, Inflammation, and Organ Protection

In mouse models of sepsis and acute kidney injury, BAM‑15 reduced mortality, decreased kidney damage, and lowered circulating mitochondrial DNA and inflammatory markers. (jci.org)

Aging and Neurodegeneration Models

Experimental research in model organisms shows improved neuronal function, reduced oxidative damage, and extended lifespan indicators following mitochondrial uncoupling with BAM‑15. (mdpi.com)

Oncology and Cellular Metabolism

BAM‑15 inhibits proliferation in certain cancer cell lines and enhances antitumor immune responses in experimental models, highlighting potential applications in oncology research. (papers.ssrn.com)

Mechanistic and Translational Reviews

Recent reviews emphasize BAM‑15’s potential role in metabolic syndrome, cardiovascular disease, and mitochondrial disorders, while noting the need for human trials and optimized delivery methods. (pubmed.ncbi.nlm.nih.gov)

Evidence synthesis indicates strong preclinical evidence for metabolic and mitochondrial benefits, with limited but promising translational research and ongoing investigation.

Usage & Quality Compliance 

Paragon Pharmatech BAM‑15 capsules are manufactured under GMP‑aligned conditions. Each batch undergoes:

• HPLC identity verification

• Potency assay

• Residual solvent testing

• Heavy metal analysis

• Microbiological testing

• Stability testing

Suggested research monitoring parameters may include metabolic biomarkers, glucose tolerance, lipid panels, inflammatory markers, and mitochondrial function assays.

Safety Note

Mitochondrial uncouplers influence cellular energy balance and require careful experimental dosing. Potential risks include:

• Excessive metabolic rate or heat production at high exposures

• Gastrointestinal discomfort or fatigue

• Altered metabolic parameters

Preclinical studies suggest improved tolerability compared with earlier uncouplers, but comprehensive human safety data are limited, and BAM‑15 remains investigational. (pubmed.ncbi.nlm.nih.gov)

Contraindications for experimental protocols may include severe cardiovascular disease, uncontrolled metabolic disorders, or concurrent investigational drugs affecting mitochondrial function.

Full Reference List 

1. Alexopoulos SJ et al. Nature Communications. Mitochondrial uncoupler BAM15 reverses diet‑induced obesity and insulin resistance. https://www.nature.com/articles/s41467‑020‑16298‑2

2. Axelrod CL et al. EMBO Molecular Medicine. BAM15 protects against obesity and improves glycemic control. https://doi.org/10.15252/emmm.202012088

3. Xiong G et al. BAM15 as a mitochondrial uncoupler: a promising therapeutic agent. https://pubmed.ncbi.nlm.nih.gov/37900126/

4. Tsuji N et al. BAM15 reduces sepsis‑associated kidney injury. https://www.jci.org/articles/view/152401

5. Cho I et al. BAM15 alleviates neurodegeneration in aging models. https://www.mdpi.com/2218‑1989/12/11/1129

6. Danielak A et al. Mitochondrial uncoupling and obesity research review. https://www.sciencedirect.com

© Paragon Pharmatech — Educational Material 2025. For scientific and educational purposes only.

Remember, this product is intended for research purposes only and should not be used for human consumption without proper medical guidance. As with any supplement, it is important to prioritize your health and safety, and to consult with a healthcare professional if you have any underlying health concerns before incorporating this product into your routine.
This product is not a food product. By acquiring this product, you are in full knowledge that it’s not a food, nor is it for human consumption and it’s for market research purposes only